⌘K

Login Start Free

Home/Insiders/Pershing Edward

PE

SEC Insider//CIK 0001689739

Pershing Edward

CIK 00016897391 companyKNOXVILLE, TN

Transactions

50

Companies

1

Filings

17

CIK

0001689739

Recent Transactions

50 trades

Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-03-05
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-02-26
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-02-20
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-02-20+47,180→ 2,660,987 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-02-19
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-02-12
Purchase
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-02-09$2.86/sh+34,940→ 2,613,807 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-02-05
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-01-30
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-01-30+37,744→ 2,578,867 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-01-28
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2026-01-16
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2026-01-16+37,744→ 2,541,123 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-12-05
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-11-26
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-11-20
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-11-13
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-11-06
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-10-30
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-10-23
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-10-16
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2025-10-16+18,880→ 2,503,379 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-10-10
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-10-03
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-09-30
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2025-09-30+66,052→ 2,484,499 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2025-09-19+37,760→ 2,418,447 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-09-19
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-09-18
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-09-11
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-09-04
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-08-29
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2025-08-29+28,320→ 2,380,687 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-08-26
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-08-22
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2025-08-22+37,760→ 2,352,367 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2025-08-08+18,880→ 2,314,607 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-08-08
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2025-07-18+62,303→ 2,295,727 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-07-18
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-06-26
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2025-06-26+122,692→ 2,233,424 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-06-20
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2025-06-20+18,880→ 2,110,732 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-06-05
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-05-23
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-05-15
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-05-07
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2025-04-29+18,876→ 2,091,852 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Unsecured Convertible Promissory Note
2025-04-29

Companies

1

PROVECTUS BIOPHARMACEUTICALS, INC.
Director, CEO
$PVCT

Recent Filings

17

Address

800 S. GAY STREET, SUITE 1610

KNOXVILLE, TN, 37929

View on SEC.gov